Overview In October 2022 Japan's Vaccines, blood, antisera, toxins and cultures exports accounted up to ¥31.3B and imports accounted up to ¥350B, resulting in a negative trade balance of ¥319B. Between October 2021 and October 2022 the exports of Japan's Vaccines, blood, antisera, toxins and cultures have increased by ¥4.16B (15.4%) from ¥27.1B to ¥31.3B, while imports increased by ¥198B (130%) from ¥153B to ¥350B.
Destinations In October 2022, Vaccines, blood, antisera, toxins and cultures were exported mostly to Switzerland (Â¥21.4B), Germany (Â¥2.77B), United Kingdom (Â¥2.65B), United States (Â¥1.2B), and South Korea (Â¥792M), and were imported mostly from Belgium (Â¥164B), United States (Â¥62.7B), Ireland (Â¥46.9B), Switzerland (Â¥20.1B), and Germany (Â¥17.2B).
Growth In October 2022, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to United States (Â¥6.49B or 925%), Germany (Â¥1.04B or 111%), and China (Â¥304M or 35.8%). In October 2022, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Ireland (Â¥15.2B or 68.1%), Belgium (Â¥3.32B or 190%), and Puerto Rico (Â¥1.25B or 98.1%).